George L. Maxwell

George L. Maxwell

Oncology | Obstetrics and Gynecology

3300 Gallows Rd
Ob/Gyn
Falls Church, VA 22042

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 166 publications

Effectiveness and Safety of Intravenous Iron Therapy in Outpatient Obstetrical Clinic for Treatment of Iron-Deficiency Anemia During Pregnancy.

Effectiveness and Safety of Intravenous Iron Therapy in Outpatient Obstetrical Clinic for Treatment of Iron-Deficiency Anemia During Pregnancy.

Journal: Pregnancy (Hoboken, N.J.)

Published: August 14, 2026

Correction: Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and Metformin.

Correction: Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and Metformin.

Journal: Oncogene

Published: August 03, 2026

Retraction: Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1.

Retraction: Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1.

Journal: Oncotarget

Published: July 21, 2026

Maternal and fetal HLA heterozygosity in preeclampsia: Insights from a large multi-ancestry pregnancy cohort.

Maternal and fetal HLA heterozygosity in preeclampsia: Insights from a large multi-ancestry pregnancy cohort.

Journal: medRxiv : the preprint server for health sciences

Published: June 29, 2026

Biobank-scale genotyping of Robertsonian translocations reveals hidden structural variation on the human acrocentric chromosomes.

Biobank-scale genotyping of Robertsonian translocations reveals hidden structural variation on the human acrocentric chromosomes.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium study.

Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 08, 2026

MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study.

MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study.

Journal: Gynecologic oncology

Published: February 15, 2026

The pioneering gut microbiome acquired via different delivery modes in neonates shapes distinct immune and metabolic environments.

The pioneering gut microbiome acquired via different delivery modes in neonates shapes distinct immune and metabolic environments.

Journal: medRxiv : the preprint server for health sciences

Published: December 31, 2025

Colibactin genes are highly prevalent in the developing infant gut microbiome.

Colibactin genes are highly prevalent in the developing infant gut microbiome.

Journal: Gut microbes

Published: December 17, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Research square

Published: November 19, 2025

RETRACTED: Waheed et al. Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A. Molecules 2019, 24, 3722.

RETRACTED: Waheed et al. Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A. Molecules 2019, 24, 3722.

Journal: Molecules (Basel, Switzerland)

Published: October 24, 2025

Progestin and vitamin D synergistically inhibit fallopian tube carcinogenesis.

Progestin and vitamin D synergistically inhibit fallopian tube carcinogenesis.

Journal: Gynecologic oncology

Published: October 23, 2025

Showing 1-12 of 166

Last Updated: 09/26/2026